Autoimmune Disease Diagnostics Market Analysis by Treatment Base Distribution and Salesby Rohit MRFR Market Research
Autoimmune Disease Diagnostics Market - Highlights
The Global Autoimmune Disease Diagnostics Market accounted for USD 3300 million and expected to register 7.6% CAGR during the forecast period (2018–2023).
Immune system provides protection to human body by reacting to foreign particles and germs like bacteria and viruses. Sometimes human immune system fails to differentiate between own cells and foreign objects and starts attacking own cells, this medical condition is called autoimmune diseases.
Avail Sample Copy for this Report https://www.marketresearchfuture.com/sample_request/6715
Some of the key players in the global autoimmune disease diagnostics market are Siemens Healthcare Private Limited, bioMérieux SA, Bio-rad Laboratories, Beckman Coulter, Inc., AstraZeneca, EUROIMMUN AG, F. Hoffmann-la Roche, Inova Diagnostics, Inc.,Myriad Genetics, Inc., Thermo Fisher Scientific, Trinity Biotech Plc., and Hemagen Diagnostics, Inc.
The global autoimmune disease diagnostics market has been segmented on the basis of disease type, test type, and end-user.
The market, by disease type, has been classified as systemic autoimmune disease, and localized autoimmune disease. The systemic autoimmune disease segment has been further classified into psoriasis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus (SLE), and others. Localized autoimmune disease segment has been divided into inflammatory bowel disease, thyroid, type 1 diabetes, and others.
On the basis of test type, the market has been segregated into western blotting, enzyme-linked immunosorbent assay (ELISA), double immune diffusion, dot blot, counter immune-electrophoresis, line blot, immunofluorescence assays (IFA), multiplex immunoassay, agglutination, and others.
The end-user segment has been divided into, has been segmented into hospitals, diagnostics centers, research laboratories, and others
Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/autoimmune-disease-diagnostics-market-6715
The Americas are likely to dominate the global autoimmune disease diagnostics market due to the well-established healthcare sector, adoption of advance technology, and rising prevalence of autoimmune disorders.
The European market is expected to be the second-largest autoimmune disease diagnostics market. The growing healthcare industry, presence of major market players in the region, and increasing automation in laboratories are the factors responsible for growth of the autoimmune disease diagnostics market in the region.
Asia-Pacific is anticipated to be the fastest-growing autoimmune disease diagnostics market during the forecast period owing to the increase in population, rising prevalence of autoimmune disorders, and initiatives by government and private organizations for development of healthcare sector.
The market in the Middle East & Africa is likely to account for the smallest share of the global autoimmune disease diagnostics market.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Created on Feb 6th 2019 02:32. Viewed 316 times.